StockData
Neuraxis, INC logo

Neuraxis, INC (NRXS) stock

NRXSNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 0/30
$4.87+0.26 (+5.64%)

Close on Nov 18, 2026Market cap $61.16MP/E –Yield –

Neuraxis cash

Cash and short-term investments held at the end of each period.

Neuraxis's cash was $8.32M at Jun 30, 2026. For fiscal 2025 it was $4.97M, up 34.3% from the year before.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$4.97M+34.3%
FY2024Dec 31, 2024$3.70M+4605.8%
FY2023Dec 31, 2023$78.56K-69.0%
FY2022Dec 31, 2022$253.70K–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$8.32M+39.0%
Q1 FY2026Mar 31, 2026$7.08M+253.0%
Q4 FY2025Dec 31, 2025$4.97M+34.3%
Q3 FY2025Sep 30, 2025$4.38M+1577.8%
Q2 FY2025Jun 30, 2025$5.99M+239.2%
Q1 FY2025Mar 31, 2025$2.01M+2353.0%
Q4 FY2024Dec 31, 2024$3.70M+4605.8%
Q3 FY2024Sep 30, 2024$260.89K-65.7%
Q2 FY2024Jun 30, 2024$1.77M+3331.7%
Q1 FY2024Mar 31, 2024$81.75K-67.8%
Q4 FY2023Dec 31, 2023$78.56K–
Q3 FY2023Sep 30, 2023$761.25K–
Q2 FY2023Jun 30, 2023$51.44K–
Q4 FY2022Dec 31, 2022$253.70K–

More Neuraxis figures

See a number that looks wrong?